Healthcare

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health’s Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health’s Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting

error: Content is protected !!